Latest Breaking News On - Stan lapidus - Page 1 : vimarsana.com

Biomed 2024 Showcases Israel s Resilient Entrepreneurial Spirit

The 22nd Biomed Israel Conference brings together Israeli Biotech startups, senior pharma and healthcare executives, and global investors.

Tel avivYaron danielyOfer sharonStan lapidusNevia bioProtica bioCytyc corpBiomed israel conferenceBiomed israelGetting closerTransforming early detectionDisease managementGeneral partnerIsraeli healthtech

Lucid Diagnostics Inc (NASDAQ:LUCD) Q1 2024 Earnings Call Transcript

Lucid Diagnostics Inc (NASDAQ:LUCD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesMatt rileyDennis mcgrathAnthony vendettiVidyun baisStan lapidusMichael matsonMedtronic cytospongeMike matsonKyle miksonLishan aklogNick shaheenMark massaroWorld trade centerNational cancerNational association

Imidex Hires Wes Bolsen as CEO to Commercialize FDA-Cleared Artificial Intelligence Device for Lung Nodule and Mass Detection, Indicative of Potential Early-Stage Lung Cancer

Imidex Hires Wes Bolsen as CEO to Commercialize FDA-Cleared Artificial Intelligence Device for Lung Nodule and Mass Detection, Indicative of Potential Early-Stage Lung Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWes bolsenStan lapidusDax craigRichard vlasimskyImidex coChief executiveImidex co founder richard vlasimskyChestx raysCo founder richard

CellMax Life Announces Expansion of Company Board With Leading Industry Experts

SUNNYVALE, Calif. April 6, 2023 (PRWEB) April 06, 2023 CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood

United statesStan lapidusStanleyn lapidus stanRon andrewsRonnie ron andrewsStanley lapidusRonnie andrewsSmithsoniannational museum of american historyCytyc corpGe healthcareClarient incOncocyte corpHologic incCellmax lifeMax lifeAtul sharan

World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board

World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board Share Article Drs. Cynthia Ma and Massimo Cristofanilli to Advise on Biomarkers of Response (BoRs) to Drive Better Treatment Outcomes for Patients with Breast Cancer I am impressed by Olaris’s technology and early data suggesting the potential use of a metabolomics signature as an independent and robust predictive biomarker in metastatic breast cancer. - Dr. Cristofanilli WALTHAM, Mass. (PRWEB) February 16, 2021 Olaris, Inc, a precision medicine company leveraging metabolomics and machine learning for the discovery and development of Biomarkers of Response (BoRs) to optimize treatments and patient outcomes, has appointed Dr. Cynthia Ma of Washington University in St. Louis and Dr. Massimo Cristofanilli from Northwestern Medicine to its Scientific Advisory Board and Medic

United statesStan lapidusMonty kothiwaleHeliocos biosciencesGerhard wagnerMassimo cristofanilliCynthia maPolaris incNuclear magnetic resonanceMolecular pharmacology at harvard medical schoolUniversity of nebraskaWashington university in stTranslational researchCytyc incWashington universityNorthwestern medicine